DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Letairis (Ambrisentan) - News


News related to Letairis (Ambrisentan) and/or conditions it is approved for

Macitentan Viable for Inoperable Pulmonary Hypertension
Source: Medscape Anesthesiology Headlines [2017.05.24]
An endothelin receptor antagonist is showing promise in the phase 2 MERIT study of patients with chronic thromboembolic pulmonary hypertension, who have few treatment options.
Medscape Medical News

Evidence review supports pediatric use of PDE-5 inhibitors for pulmonary hypertension
Source: Hypertension News From Medical News Today [2017.02.28]
A systematic review of the comparative effectiveness and safety of phosphodiesterase type 5 (PDE-5) inhibitors in pediatric patients with pulmonary hypertension published in Pediatrics demonstrates...

-- advertisement -- The American Red Cross
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017